FIELD: pharmaceutics; medicine.
SUBSTANCE: object 1 is the use of a combination of an antibody or its fragment with immunological reactivity to an extracellular domain of protein CAPRIN-1 present on the surface of cells of malignant tumor and having an amino acid sequence shown in any of even SEQ ID NO: from 2 to 30, or an amino acid sequence 80% or more identical to this amino acid sequence, and imiquimod together or separately in a combination for the treatment and/or prevention of malignant tumor expressing protein CAPRIN-1 on the surface of cell membrane. Objects 2 and 3 are the use of imiquimod and the use of an antibody or its fragment for increasing therapeutic efficiency of a pharmaceutical composition for the treatment and/or prevention of malignant tumor. Object 4 is a method for the treatment and/or prevention of malignant tumor, including the introduction to an individual of an antibody or its fragment and imiquimod together or separately.
EFFECT: synergetic antitumor effect in the treatment with the claimed combination of an antibody or its fragment and imiquimod.
11 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND/OR PREVENTION OF MALIGNANT TUMOR | 2017 |
|
RU2766586C2 |
MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
INFLUENZA VIRUS CAPABLE OF INFECTING CANINES AND ITS USE | 2020 |
|
RU2802222C2 |
METHOD OF PRODUCING PRECURSOR RENAL CELLS | 2016 |
|
RU2730861C2 |
GENE THERAPY OF HYPOPHOSPHATEMIC DISEASES ASSOCIATED WITH FIBROBLAST GROWTH FACTOR 23 | 2020 |
|
RU2815545C2 |
BIOSENSOR SYSTEM FOR FAST DETECTION OF DETERMINED COMPONENTS | 2016 |
|
RU2717658C2 |
PORCINE PARVOVIRUS | 2015 |
|
RU2817872C2 |
NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
ORAL CARE PRODUCTS AND METHODS CONTAINING HLP | 2016 |
|
RU2759134C2 |
IMMUNO-INDUCING AGENT | 2016 |
|
RU2744843C2 |
Authors
Dates
2022-10-13—Published
2019-03-29—Filed